ICTS International N.V. (ICTSF)

Revance Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 21, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	131	168	150	215	341	150
Market Cap Growth	11.94%	11.94%	-30.09%	-36.81%	127.50%	57.25%
Enterprise Value	155	194	182	236	355	192
Last Close Price	3.50	4.50	4.02	5.75	9.10	4.00
PE Ratio	-	-	21.25	-	13.79	34.01
PS Ratio	0.27	0.35	0.35	0.66	1.05	0.60
PB Ratio	1.55	2.00	1.66	2.70	4.02	3.34
P/FCF Ratio	-	-	53.02	-	6.56	6.80
P/OCF Ratio	-	-	34.29	-	6.38	6.18
EV/Sales Ratio	0.32	0.40	0.42	0.73	1.09	0.77
EV/EBITDA Ratio	42.01	-	14.63	-	6.58	19.14
EV/EBIT Ratio	-	-	16.99	-	6.80	23.75
EV/FCF Ratio	-13.61	-	64.23	-	6.83	8.70
Debt / Equity Ratio	0.19	0.19	0.08	0.15	0.16	0.50
Debt / EBITDA Ratio	4.42	4.42	0.40	2.70	0.22	1.46
Debt / FCF Ratio	-	-	2.70	-	0.26	1.02
Asset Turnover	2.53	2.53	2.26	1.71	1.93	1.88
Quick Ratio	1.95	1.95	2.02	2.00	2.58	1.71
Current Ratio	2.04	2.04	2.19	2.28	2.87	1.96
Return on Equity (ROE)	-4.45%	-4.45%	12.40%	-6.37%	63.77%	12.95%
Return on Assets (ROA)	-1.89%	-1.89%	3.51%	-1.18%	19.39%	3.82%
Return on Capital (ROIC)	-3.63%	-3.63%	7.06%	-2.38%	39.43%	7.12%
Return on Capital Employed (ROCE)	-	-	9.20%	-	38.60%	10.00%
Earnings Yield	-3.23%	-2.51%	4.71%	-2.20%	10.22%	2.94%
FCF Yield	-8.72%	-6.78%	1.89%	-1.79%	15.25%	14.72%
Buyback Yield / Dilution	5.05%	5.05%	-5.32%	6.97%	-4.72%	-25.88%

Updated Dec 20, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.